Antares Pharma Inc (ATRS)

2.94
0.01 0.34
NASDAQ : Health Care
Prev Close 2.93
Open 2.94
Day Low/High 2.93 / 2.96
52 Wk Low/High 0.67 / 2.25
Volume 780.16K
Avg Volume 1.39M
Exchange NASDAQ
Shares Outstanding 156.41M
Market Cap 452.02M
EPS -0.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Stocks Under $10 Weekly Summary

We scaled into one position during a week dominated by Hurricane Harvey and its aftermath.

Stocks Under $10 Weekly Summary

We initiated 2 small positions last week as the market moved higher.

Commit To Purchase Antares Pharma At $2.50, Earn 42.4% Annualized Using Options

Investors considering a purchase of Antares Pharma Inc. shares, but tentative about paying the going market price of $3.06/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Stocks Under $10 Weekly Summary

We used last week's weakness to scale into several positions.

Stocks Under $10 Weekly Summary

North Korea puts a worrying wrinkle in the markets. We add to 2 portfolio positions.

Antares and Amplify Brands Reports; Plus Other Earnings News

Five portfolio names report today. Here is what we have seen, and what two expect after the closing bell.

Antares Pharma Reports Second Quarter 2017 Operating And Financial Results

Antares Pharma Reports Second Quarter 2017 Operating And Financial Results

Revenue of $13.4 Million and Net Loss Per Share of $0.02

Stocks Under $10 Weekly Summary

It was a rough week for the portfolio.

Stocks Under $10 Weekly Summary

We made several trades and price target changes during a mixed week for the portfolio.

Stocks Under $10 Weekly Summary

The portfolio has some high fliers and underperformers last week as we head into the heart of earnings season.

Stocks Under $10 Weekly Summary

We brought a new name into the portfolio last week as the Fed's comments helped lift the market.

Stocks Under $10 Weekly Summary

We made no trades during the holiday-shortened week, but added to our natural hedge today.

Stocks Under $10 Weekly Summary

We added a name to the portfolio's Bullpen as a whirlwind quarter came to an end.

Stocks Under $10 Weekly Summary

We exited 2 positions and took some profits during a busy week for the portfolio.

Stocks Under $10 Weekly Summary

We initiated a new position and made several other trades during a week of twists and turns.

Stocks Under $10 Weekly Summary

We initiated 2 new positions in a week dominated by political events.

Antares Pharma Announces Debt Financing From Hercules Capital

Five Year Term Loan Agreement Provides Up To $35 Million

Stocks Under $10 Weekly Summary

We exited 3 names last week as stocks continued their run.

Interesting ATRS Put Options For July 21st

Investors in Antares Pharma Inc. saw new options begin trading this week, for the July 21st expiration.

Stocks Under $10 Weekly Summary

It was a busy week of moves in the portfolio as we head into the latter half of the second quarter.

Stocks Under $10 Weekly Summary

We initiated one new position and exited another last week, while several other names reported earnings.

Digging Into Amplify and Antares Results

BETR and ATRS report March-quarter numbers. Plus, post-call commentary on USA Technologies.

Antares Pharma Reports First Quarter 2017 Operating And Financial Results

Multiple Drug Device Combination Products Pending FDA Approval

Stocks Under $10 Weekly Summary

We add a new name to the portfolio during a busy week of earnings.

TheStreet Quant Rating: D (Sell)